"Multifactorial Risk Stratification in Acute and Chronic Cardiovascular Disease"
NCT ID: NCT05472207
Last Updated: 2024-11-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
5000 participants
OBSERVATIONAL
2021-01-01
2030-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Management of Cardiovascular Risk Factors
NCT00848380
Personalized Evaluation of Susptected Myocardial Ischemia
NCT06708000
Biomarkers in Acute Cardiac Care
NCT02355457
Cardiovascular Risk Early Screening and Warning in Harbin : A Prospective Cohort Study
NCT07033624
Cardiac Biomarkers and Analytical Methods
NCT05781724
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with cardiovascular diseases
Recording clinical data - especially risk parameters - from patients suffering from cardiovascular diseases
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Acute or chronic condition due to structural, rhythmologic, or inflammatory cardiovascular disease
* Informed consent for participation in the clinical trial
Exclusion Criteria
* pregnant or breast-feeding women
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medical University Innsbruck
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Univ. Prof. Dr. Axel Bauer
Univ.-Prof. Dr.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Medizinische Universität Innsbruck, Universitätsklinik für Innere Medizin III, Kardiologie & Angiologie
Innsbruck, Tyrol, Austria
Reha Zentrum Münster
Münster, Tyrol, Austria
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Theresa Dolejsi, Dr.
Role: backup
Michael Schreinlechner, Dr.
Role: backup
Michael Toifl, DI
Role: backup
Nikolay Sappler, Dr.
Role: backup
Fabian Theurl, Dr.
Role: backup
Rudolf Kirchmair, Ao. Univ.Prof.Dr.
Role: primary
Theresa Dolejsi, Dr.
Role: backup
Michael Schreinlechner, Dr.
Role: backup
Nikolay Sappler, Dr.
Role: backup
Fabian Theurl, Dr.
Role: backup
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
1328/2020
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.